Thursday, March 21, 2019 8:11:40 AM
Yes he was at the center in Houston.
He was diagnosed with anaplastic oligodendroglioma in 2010. He had his second surgery in 2016 and it stayed AO3. In 2018 he had a surgery in March and that is when it progressed to GBM. He did another round of radiation (his first was in 2010) and it returned and had his 4th craniotomy in December. He started his clinical trial on January 10th. It was an OxPhos Inhibitor. It was a phase 1 trial. The drug was developed at MD Anderson. He developed a staph infection at the incision site and had a clean out surgery on January 23. After the surgery we learned the trial was not working. He died on Feb 8th.
Unfortunately he was not a candidate for immunotherapy. From my understanding the tumor was too close to a ventricle so it would be too dangerous to try.
I know I haven’t been around this company as long as others, but these few years that I have been invested have felt like forever. I feel as though it’s time to shit or get off the pot for Ms Powers. So I’m definitely not a bear, I have invested a ton, I have friends who have invested a ton. Just ready to know.
He was diagnosed with anaplastic oligodendroglioma in 2010. He had his second surgery in 2016 and it stayed AO3. In 2018 he had a surgery in March and that is when it progressed to GBM. He did another round of radiation (his first was in 2010) and it returned and had his 4th craniotomy in December. He started his clinical trial on January 10th. It was an OxPhos Inhibitor. It was a phase 1 trial. The drug was developed at MD Anderson. He developed a staph infection at the incision site and had a clean out surgery on January 23. After the surgery we learned the trial was not working. He died on Feb 8th.
Unfortunately he was not a candidate for immunotherapy. From my understanding the tumor was too close to a ventricle so it would be too dangerous to try.
I know I haven’t been around this company as long as others, but these few years that I have been invested have felt like forever. I feel as though it’s time to shit or get off the pot for Ms Powers. So I’m definitely not a bear, I have invested a ton, I have friends who have invested a ton. Just ready to know.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
